Last reviewed · How we verify

NCT04400942

Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy

Status unknown Last updated 4 March 2021
What this trial tests

trial testing Transvaginal ultrasound in Uterine Fibroids in 600 participants. Status unknown.

Timeline
1 January 2015
Primary endpoint
1 December 2021
1 December 2021

Quick facts

Lead sponsorOspedale Policlinico San Martino
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment600
Start date1 January 2015
Primary completion1 December 2021
Estimated completion1 December 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Ospedale Policlinico San Martino

Who can join

18 and older, female only, with Uterine Fibroids or Uterine Myomas. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational retrospective analysis is to evaluate predictive factors for complete myoma resection during hysteroscopic myomectomy for developing and validating a nomogram. This tool can help clinicians to support the patient in making an informed decision about therapeutic options for uterine submucous myomas by defining risk factors predicting a high complexity myomectomy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transvaginal ultrasound

Trials testing the same drug.

Other recruiting trials for Uterine Fibroids

Currently open trials in the same condition.

Other Ospedale Policlinico San Martino trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04400942.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing